1. Home
  2. SCHL vs OABI Comparison

SCHL vs OABI Comparison

Compare SCHL & OABI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholastic Corporation

SCHL

Scholastic Corporation

N/A

Current Price

$36.13

Market Cap

672.6M

ML Signal

N/A

Logo OmniAb Inc.

OABI

OmniAb Inc.

N/A

Current Price

$4.95

Market Cap

696.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SCHL
OABI
Founded
1920
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
672.6M
696.4M
IPO Year
1995
2021

Fundamental Metrics

Financial Performance
Metric
SCHL
OABI
Price
$36.13
$4.95
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $8.40
AVG Volume (30 Days)
381.9K
★ 1.3M
Earning Date
09-24-2026
11-03-2026
Dividend Yield
★ 2.84%
N/A
EPS Growth
★ 3442.86
6.56
EPS
N/A
★ N/A
Revenue
★ $1,487,100,000.00
$18,666,000.00
Revenue This Year
$2.14
$87.33
Revenue Next Year
$3.42
$24.38
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$26.38
$1.32
52 Week High
$48.07
$5.43

Technical Indicators

Market Signals
Indicator
SCHL
OABI
Relative Strength Index (RSI) 43.84 65.70
Support Level $32.81 $1.90
Resistance Level $35.89 $5.43
Average True Range (ATR) 1.14 0.26
MACD 0.25 -0.00
Stochastic Oscillator 75.14 94.62

Price Performance

Historical Comparison
SCHL
OABI

About SCHL Scholastic Corporation

Scholastic Corp is a publisher and distributor of children's books, a provider of print and digital instructional materials for grades pre-kindergarten (pre-K) to grade 12 and a producer of entertaining literary and educational children's media. The company creates quality print, digital and audio books, learning materials and programs, classroom magazines and other products that, in combination, offer children, families and educators engaging and comprehensive solutions to support children's learning and reading both at home and at school. It categorizes its businesses into four reportable segments: Children's Book Publishing and Distribution; Education; Entertainment; and International. It derives the majority of revenue from Children's Book Publishing and Distribution segment.

About OABI OmniAb Inc.

OmniAb Inc licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of next-generation therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. At the heart of the OmniAb platform is what it calls Biological Intelligence, which powers the immune systems of proprietary, engineered transgenic animals to create optimized antibody candidates for human therapeutics.

Share on Social Networks: